Different studies have shown that the expression of programmed death‐ligand 1 (PD‐L1) is highly associated with favorable overall survival, indicating that targeting PD‐L1 may be useful in PD‐L1‐positive ESCC patients.9, 10, 11, 12. The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.